The Effect of Anticonvulsants on Bone Mineral Density: Brief Review
https://doi.org/10.52667/2712-9179-2023-3-2-32-37
Abstract
The effect of anticonvulsants on bone mineral density changes in epileptic patients is an important and relevant scientific question. This brief review focuses on assessing the existing knowledge on how antiepileptic drugs affect bone mineral density. The review examines the various mechanisms that may influence bone mineral density when anticonvulsants are taken. Based on a literature search and analysis, advances in the field are identified and their contribution to the current understanding of the issue is assessed. Overall, this review can serve as an informative resource for understanding the relationship between antiepileptic drugs and bone mineral density and as a direction for future research.
Keywords
epilepsy,
bone mineral density,
osteoporosis,
osteopenia,
densitometry,
antiepileptic drugs,
anticonvulsants
Supporting agencies: Supported by Russian Science Foundation № 23-25-00104, https://rscf.ru/en/project/23-25-00104
About the Authors
N. A. Sivakova
V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Russian Federation
Russian Federation
Natalia A. Sivakova
192019 St. Petersburg
Tel.: 8 (812) 670-02-20
I. V. Abramova
V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Russian Federation
Russian Federation
Irina V. Abramova
192019 St. Petersburg
V. P. Rybasova
V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Russian Federation
Russian Federation
Varvara P. Rybasova
192019 St. Petersburg
I. Yu. Trukhina
V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Russian Federation
Russian Federation
Irina Yu. Trukhina
192019 St. Petersburg
L. V. Lukina
V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Russian Federation
Russian Federation
Larisa V. Lukina
192019 St. Petersburg
R. F. Nasyrova
V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Russian Federation
Russian Federation
Regina F. Nasyrova
192019 St. Petersburg
V. A. Mikhailov
V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Russian Federation
Russian Federation
Vladimir A. Mikhailov
192019 St. Petersburg
G. E. Mazo
V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Russian Federation
Russian Federation
Galina E. Mazo
192019 St. Petersburg
References
1. Meena, U.K.; Meena, D.S.; Behera, P.; Meel, O.S. Bilateral central acetabular fracture dislocation in a young patient due to seizure activity: a case report and review of the literature. Chinese Journal of Traumatology. 2014; 17(6): 364-366. DOI: 10.3760/cma.j.issn.1008-1275.2014.06.015
2. Mattson, R.H.; Gidal, B.E. Fractures, epilepsy, and antiepileptic drugs. Epilepsy Behav. 2004; 5(2): 36–40. DOI: 10.1016/j.yebeh.2003.11.030
3. Svalheim, S.; Roste, L.S.; Nakken, K.O.; Tauboll, E. Bone health in adults with epilepsy. Acta Neurol Scand Suppl. 2011; (191): 89-95. DOI: 10.1111/j.1600-0404.2011.01551.x.
4. Salimipour, H.; Kazerooni, S.; Seyedabadi, M.; Nabipour, I.; Nemati, R.; Iranpour, D.; Assad, M. Antiepileptic treatment is associated with bone loss: difference in drug type and region of interest. Journal of nuclear medicineиtechnology. 2013; 41(3): 208-211. DOI:10.2967/jnmt.113.124685
5. Grzonka, P.; Rybitschka, A.; De Marchis, G.M.; Marsch, S.; Sutter, R. Bone fractures from generalized convulsive seizures and status epilepticus-A systematic review. Epilepsia. 2019; 60(5): 996-1004. DOI: 10.1111/epi.14738.
6. Belaya, Z.E.; Belova, K.Yu.; Biryukova, E.V.; Dedov, I.I.; Dzeranova, L.K.; Drapkina, O.M.; Dreval, A.V.; Dubovitskaya, T.A.; Dudinskaya, E.N.; Ershova, O.B.; Zagorodniy, N.V.; Ilyukhina, O.B.; Kanis, J.A.; Kryukova, I.V.; Lesnyak, O.M.; Mamedova, E.O.; Marchenkova, L.A.; Mel’nichenko, G.A.; Nikankina, L.V.; Nikitinskaya, O.A.; Petryaikin, A.V.; Pigarova, E.A.; Rodionova, S.S.; Rozhinskaya, L.Y.; Skripnikova, I.A.; Tarbaeva, N.V.; Tkacheva, O.N.; Toroptsova, N.V.; Farba, L.Y.; Tsoriev, T.T.; Chernova, T.O.; Yureneva, S.V.; Yakushevskaya, O.V. Federal clinical guidelines for diagnosis, treatment and prevention of osteoporosis. Osteoporosis and Bone Diseases. 2021; 24(2): 4-47. (In Russ.). https://doi.org/10.14341/osteo12930
7. Zasedateleva, I.Y. Mineral metabolism disorders in patients with epilepsy. Scientific notes. 2005; 12(1): 43-44. (In Russ.).
8. Asadi-Pooya, A.A.; Tomson, T. A reappraisal of injuries and accidents in people with epilepsy. Curr Opin Neurol. 2021; 34(2): 182-187. doi: 10.1097/WCO.0000000000000900.
9. Pack, A.M.; Morrell, M.J. Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications. CNS Drugs. 2001; 15: 633–642. DOI: 10.2165/00023210-200115080-00006
10. Shen, C.; Chen, F.; Zhang, Y.; Guo, Y. and Ding, M. Association between use of antiepileptic drugs and fracture risk: a systematic review and meta-analysis. Bone. 2014; 64: 246-253. DOI: 10.1016/j.bone.2014.04.018.
11. Neznanov, N.G. A paradigm shift to treat psychoneurological disorders. Personalized Psychiatry and Neurology. 2021; 1(1): 1-2
12. Dobrovolskaya, O.V.; Toroptsova, N.V.; Lesnyak, O.M. Economic aspects of complicated osteoporosis: The cost of treatment in the first year after fracture. Modern Rheumatology Journal. 2016; 10(3): 29–34. (In Russ.). DOI: http://dx.doi.org/10.14412/1996-7012-2016-3-29-34
13. Stewart, T.L.; Ralston, S.H. Role of genetic factors in the pathogenesis of osteoporosis. Journal of Endocrinology. 2000; 166(2): 235-246. DOI: 10.1677/joe.0.1660235
14. Melnichenko, G.A.; Mamedova, E.O. Iatrogenic lesions of the skeleton Obesity and metabolism. 2016; 13(2): 41-47. DOI: 10.14341/OMET2016241-47
15. Chandrasekaran, V.; Pasco, J.A.; Stuart, A.L.; Brennan-Olsen, S.L.; Berk, M.; Hodge, J.M.; Samarasinghe, R.M.; Williams, L.J. Anticonvulsant use and bone health in a population-based study of men and women: cross-sectional data from the Geelong Osteoporosis Study. BMC Musculoskelet Disord. 2021; 22(1): 172. DOI: 10.1186/s12891-021-04042-w.
16. https://www.who.int/ru/news-room/fact-sheets/detail/epilepsy (accessed on 01/10/2023).
17. Kruse, R. Osteopathies in antiepileptic long-term therapy (preliminary report). Monatsschrift fur Kinderheilkunde. 1968; 116(6): 378-381. PMID: 4304972
18. Cummings, S.R.; Nevitt, M.C.; Browner, W.S.; Stone, K.; Fox, K.M.; Ensrud, K.E.; Cauley, J.; Black, D.; Vogt, T.M. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995; 332(12): 767–773. DOI: 10.1056/NEJM199503233321202
19. Desai, K.B.; Ribbans, W.J.; Taylor, G.J. Incidence of five common fractures in an institutionalized epileptic population. Injury. 1996; 27(2): 97–100. doi: 10.1016 /0020-1383 (95)00189-1.
20. Vestergaard, P.; Rejnmark, L.; Mosekilde, L.; Vestergaard, P. Fracture risk associated with use of antiepileptic drugs. Epilepsia. 2004; 45(11):1330-1337. doi: 10.1111/j.0013-9580.2004.18804.x.Epilepsia.
21. Zhidkova, I.A.; Kaznacheeva, T.V.; Demidova, E.Yu.; Berseneva, V.V. Molecular mechanisms responsible for the impact of antiepileptic therapy on bone mineral density of epileptic patients. Neurology, neuropsychiatry, psychosomatics. 2016; Special Issue 1:59-65. (In Russ.). DOI: http://dx.doi.org/10.14412/2074-2711-2016-1S-59-65
22. Meier, C.; Kraenzlin, M.E. Antiepileptics and bone health. Therapeutic advances in musculoskeletal disease. 2011; 3(5): 235-243. DOI: 10.1177/1759720X11410769
23. Fuleihan, G.E.H. et al. Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone. 2008; 43(1): 149-155. DOI: 10.1016/j.bone.2008.03.002
24. Mehičević, A.; Mehmedika-Suljić, E.; Mahmutbegović, N. Long-term lamotrigine treatment and bone metabolism. Medical Journal. 2018; 24(1). DOI: 10.5644/ama2006-124.303
25. Sheth, R.D.; Hermann, B.P. Bone mineral density with lamotrigine monotherapy for epilepsy. Pediatr Neurol. 2007; 37: 250–254. DOI: 10.1016/j.pediatrneurol.2007.05.018.
26. Verrotti, A.; Coppola, G.; Parisi, P.; Mohn, A.; Chiarelli, F. Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg. 2010; 112(1): 1-10. DOI: 10.1016/j.clineuro.2009.10.011.
27. Lee, R.H.; Lyles, K.W.; Colón-Emeric, C. A review of the effect of anticonvulsant medications on bone mineral density and fracture risk. The American journal of geriatric pharmacotherapy. 2010; 8(1): 34-46. DOI: 10.1016/j.am-jopharm.2010.02.003.
28. Diemar, S.S.; Sejling, A.S.; Eiken, P.; Andersen, N.B.; Jørgensen, N.R. An explorative literature review of the multifactorial causes of osteoporosis in epilepsy. Epilepsy Behav. 2019; 100(PtA): 106511. DOI: 10.1016/j.yebeh.2019.106511.
29. Beniczky, S.A.; Viken, J.; Jensen, L.T.; Andersen, N.B. Bone mineral density in adult patients treated with various antiepileptic drugs. Seizure. 2012; 21(6): 471-2. DOI: 10.1016/j.seizure.2012.04.002.
30. Zhuo, L.; Zhang, Y. Effects of new antiseizure medication on bone metabolism and bone mineral density in children: A meta-analysis. Front Pediatr. 2022; 10: 1015691. DOI: 10.3389/fped.2022.1015691.
31. Elliott, J.O.; Moore, J.L.; Lu, B. Health status and behavioral risk factors among persons with epilepsy in Ohio based on the 2006 Behavioral Risk Factor Surveillance System. Epilepsy Behav. 2008; 12(3): 434-44. DOI: 10.1016/j.yebeh.2007.12.001.
Review
For citations:
Sivakova N.A., Abramova I.V., Rybasova V.P., Trukhina I.Yu., Lukina L.V., Nasyrova R.F., Mikhailov V.A., Mazo G.E. The Effect of Anticonvulsants on Bone Mineral Density: Brief Review. Personalized Psychiatry and Neurology. 2023;3(2):32-37. https://doi.org/10.52667/2712-9179-2023-3-2-32-37
Views:
404
Email this article 